Gericke N200 Nibbler Provides Size Reduction - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gericke N200 Nibbler Provides Size Reduction


Pharmaceutical Technology
Volume 38, Issue 1, pp. 16
The N200 Pharma Nibbler offers a 200 mm diameter inlet and throughput of 1.500 (1/h), providing an alternative to hammer mills and more complex equipment for consistent size reduction of materials and agglomerates found in pharmaceutical production. Products enter the inlet either by a dump or controlled feed where a paddle assembly then rotates the product inside the size reduction chamber at a slow rotational speed. Attrition milling shears the product through the screen where it is discharged through the single outlet. The N200 Nibbler model features high capacity size reduction, a compact design, low power consumption and noise levels, minimum product temperature rise and fines generation, consistent particle size, and low rotational speed. It is suitable for glove box mounting and offers easy basket removal to provide improved access for cleaning.

Powder Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here